[Effects of FK506 on neuroendocrine system--special reference to the effects on growth hormone secretory systems].
Sato
M
M
D000818:Animals; D000900:Anti-Bacterial Agents / Q000378:metabolism / Q000494:pharmacology*; D019703:Calcineurin / Q000378:metabolism; D017868:Cyclic AMP-Dependent Protein Kinases / Q000378:metabolism; D013006:Growth Hormone / Q000235:genetics / Q000378:metabolism*; D006801:Humans; D007378:Interleukins / Q000494:pharmacology / Q000502:physiology; D010903:Pituitary Gland, Anterior / Q000378:metabolism; D011493:Protein Kinase C / Q000378:metabolism; D016559:Tacrolimus / Q000378:metabolism / Q000494:pharmacology*; D022061:Tacrolimus Binding Protein 1A / Q000378:metabolism; D015533:Transcriptional Activation / Q000187:drug effects
D000900:Anti-Bacterial Agents; D007378:Interleukins; D013006:Growth Hormone; D017868:Cyclic AMP-Dependent Protein Kinases; D011493:Protein Kinase C; D019703:Calcineurin; D022061:Tacrolimus Binding Protein 1A; D016559:Tacrolimus